# PREOPERATIVE GONADOTROPINE-RELEASING HORMONE AGONIST THERAPY BEFORE SURGERY FOR UTERİN FIBROIDS

> **NCT04192812** · NA · UNKNOWN · sponsor: **Alkü Alanya Education and Research Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Uterine Fibroid
- Gonadotropin-Releasing Hormone-Dependent Precocious Puberty

## Interventions

- **DRUG:** PREOPERATİVE GnRHa THERAPY (LEUPROLIDE ACETATE) BEFORE SURGERY FOR UTERİN FIBROIDS
- **DRUG:** NO GnRHa

## Key facts

- **NCT ID:** NCT04192812
- **Lead sponsor:** Alkü Alanya Education and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-30
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04192812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04192812, "PREOPERATIVE GONADOTROPINE-RELEASING HORMONE AGONIST THERAPY BEFORE SURGERY FOR UTERİN FIBROIDS". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04192812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*